by Ivo De Nooijer | Nov 12, 2024 | Blog
Drug development is a long, expensive, and risky process. It takes an average of 10-15 years and requires a multi billion investment to bring a new drug from the laboratory to patients. Despite these costs, only about 10% of drugs that begin clinical trials ever...
by Ivo De Nooijer | Oct 17, 2024 | Blog
Orfenix welcomes a recently published report of the Medicines Patent Pool, in partnership with Boston Consulting Group, shows how voluntary licensing brings both improved access to medicines, in particular in low and middle-income countries and economic benefits to...
by Ivo De Nooijer | Oct 17, 2024 | Blog
Orfenix is proud to announce that Ivo de Nooijer has formally joined Orfenix as a shareholder and partner as of 1 July 2024. Vincent van de Wel, the founder, said, “Ivo joining this team is the next step in the development of Orfenix; Ivo brings extensive expertise in...